Selectis Health to be Acquired by Black Pearl for $5.75 Per Share

Selectis Health, traded on the OTCQB market under the ticker symbol GBCS, has agreed to be acquired by affiliates of Black Pearl Equities. The healthcare company's market capitalization will be valued based on the $5.75 per share offer. To put this into perspective, the OTCQB market is a platform for trading over-the-counter securities, which are not listed on major exchanges like the NYSE or NASDAQ.

Key facts of the deal include the all-cash consideration of $5.75 per share for Selectis stockholders, with no financing contingencies. The transaction is expected to close in Q3 2026, subject to at least 70% of outstanding shares being tendered and regulatory approvals. Following the tender offer, a short-form merger under Utah law will be completed, resulting in Selectis becoming a wholly owned subsidiary of Black Pearl. Krystal Echart, interim CEO and CFO of Selectis, noted that the transaction provides immediate cash value to stockholders at a meaningful premium, reflecting the team's dedication and portfolio strength.

The deal's structure and timeline indicate a strategic move by Black Pearl to expand its portfolio. With the acquisition, Black Pearl will gain control of Selectis Health's operations and assets, potentially leading to increased efficiency and growth. The $5.75 per share offer represents a significant premium for Selectis stockholders, who will receive immediate cash value for their shares. As the deal progresses, investors will be watching for the tender offer to commence and for regulatory approvals to be obtained.

What to watch next: the tender offer's commencement and the regulatory approval process, which will determine the deal's success and timeline.